Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
46,125,421
-
Share change
-
+701,416
-
Total reported value
-
$779,033,473
-
Put/Call ratio
-
292%
-
Price per share
-
$16.89
-
Number of holders
-
141
-
Value change
-
+$20,589,018
-
Number of buys
-
77
-
Number of sells
-
51
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q4 2014
As of 31 Dec 2014,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,125,421 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT CO, VANGUARD GROUP INC, FMR LLC, GOLDMAN SACHS GROUP INC, BlackRock Fund Advisors, BB Biotech AG, WELLINGTON MANAGEMENT GROUP LLP, State Street Corp, and BlackRock Institutional Trust Company, N.A..
This page lists
141
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.